About Tolero Pharma
Tolero Pharma is a company based in Lehi (United States) founded in 2011 was acquired by Sumitomo Dainippon Pharma in December 2016.. Tolero Pharma has raised $48.23 million across 4 funding rounds from investors including Alger and Sumitomo Dainippon Pharma. The company has 17 employees as of December 31, 2016. Tolero Pharma operates in a competitive market with competitors including Moderna, BeiGene, Incyte, Regeneron Pharmaceuticals and MorphoSys, among others.
- Headquarter Lehi, United States
- Employees 17 as on 31 Dec, 2016
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$48.23 M (USD)
in 4 rounds
-
Latest Funding Round
$8.2 M (USD), Series B
Dec 05, 2014
-
Investors
Alger
& 1 more
-
Employee Count
17
as on Dec 31, 2016
-
Acquired by
Sumitomo Dainippon Pharma
(Dec 21, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Tolero Pharma
Tolero Pharma has successfully raised a total of $48.23M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $8.2 million completed in December 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $8.2M
-
First Round
First Round
(27 Jul 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2014 | Amount | Series B - Tolero Pharma | Valuation | Alger |
|
| Nov, 2014 | Amount | Series B - Tolero Pharma | Valuation |
investors |
|
| Aug, 2014 | Amount | Series B - Tolero Pharma | Valuation | Alger |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tolero Pharma
Tolero Pharma has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Alger and Sumitomo Dainippon Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
ESG investments are managed by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Pharmaceuticals, food ingredients, additives, and veterinary products are manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tolero Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tolero Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tolero Pharma Comparisons
Competitors of Tolero Pharma
Tolero Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Incyte, Regeneron Pharmaceuticals and MorphoSys, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Antibodies are developed for treating cancer, eye, and inflammatory diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutic antibodies for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tolero Pharma
Frequently Asked Questions about Tolero Pharma
When was Tolero Pharma founded?
Tolero Pharma was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Tolero Pharma located?
Tolero Pharma is headquartered in Lehi, United States. It is registered at Lehi, Utah, United States.
Is Tolero Pharma a funded company?
Tolero Pharma is a funded company, having raised a total of $48.23M across 4 funding rounds to date. The company's 1st funding round was a Series B of $14.2M, raised on Jul 27, 2012.
How many employees does Tolero Pharma have?
As of Dec 31, 2016, the latest employee count at Tolero Pharma is 17.
What does Tolero Pharma do?
Tolero Pharma was founded in 2011 and is based in Lehi, United States. Operations focus on the development of therapeutics targeting biological drivers of blood disorders, including leukemias and anemia. The pipeline features an immunotherapeutic cancer vaccine as the lead candidate, along with inhibitors for AXL, CDK9, ALK2, PIM, and BTK. Efforts center on oncology within the biopharmaceutical sector.
Who are the top competitors of Tolero Pharma?
Tolero Pharma's top competitors include Moderna, BeiGene and Strand Therapeutics.
Who are Tolero Pharma's investors?
Tolero Pharma has 2 investors. Key investors include Alger, and Sumitomo Dainippon Pharma.